Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy - the prospective-randomized MAYDAY-trial.

Anker AM, Ruewe M, Prantl L, Baringer M, Pawlik MT, Zeman F, Goecze I, Klein SM

Open source

DOI
10.1038/s41598-024-68079-2
Published
2024 Jul 24
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-024-68079-2,
  title = {Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy - the prospective-randomized MAYDAY-trial.},
  author = {Anker AM and Ruewe M and Prantl L and Baringer M and Pawlik MT and Zeman F and Goecze I and Klein SM},
  year = {2024},
  journal = {Scientific reports},
  doi = {10.1038/s41598-024-68079-2},
  url = {https://doi.org/10.1038/s41598-024-68079-2}
}

RIS

TY  - JOUR
TI  - Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy - the prospective-randomized MAYDAY-trial.
AU  - Anker AM
AU  - Ruewe M
AU  - Prantl L
AU  - Baringer M
AU  - Pawlik MT
AU  - Zeman F
AU  - Goecze I
AU  - Klein SM
PY  - 2024
JO  - Scientific reports
DO  - 10.1038/s41598-024-68079-2
UR  - https://doi.org/10.1038/s41598-024-68079-2
ER  - 

APA

AM, A., M, R., L, P., M, B., MT, P., F, Z., I, G., & SM, K. (2024). Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy - the prospective-randomized MAYDAY-trial.. Scientific reports. https://doi.org/10.1038/s41598-024-68079-2

Source records